Sort   by:  
 Page size 
UnknownSpecialized sledge dogs accompanied Inuit dispersal across the North American Arctic.
Not available
S-EPMC6939252 | biostudies-literature
UnknownImpact of primary breast cancer therapy on energetic capacity and body composition.
Not available
S-EPMC6208924 | biostudies-literature
UnknownGermline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE.
Not available
S-EPMC11014938 | biostudies-literature
UnknownImpact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
Not available
S-EPMC9086123 | biostudies-literature
UnknownTreatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.
Not available
S-EPMC4289722 | biostudies-literature
UnknownCytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.
Not available
S-EPMC10411392 | biostudies-literature
UnknownCYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108.
Not available
S-EPMC12167464 | biostudies-literature
UnknownTrastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.
Not available
S-EPMC4226805 | biostudies-literature
UnknownCharacterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.
Not available
S-EPMC3901081 | biostudies-literature
UnknownExemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.
Not available
S-EPMC3612593 | biostudies-literature
Sort   by:  
 Page size